金城医药 (300233.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(金城医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2021年中报2021年一季报2020年年报2020年三季报2020年中报2020年一季报2019年年报2019年三季报2019年中报2019年一季报
主要指标:
 营业收入(元) 1,295,172,553.06608,977,257.172,961,935,834.221,936,858,726.931,273,354,991.10650,685,404.332,794,819,332.701,964,362,438.541,281,977,257.53634,385,558.13
 营业利润(元) 131,260,254.8768,311,968.89-414,814,685.50263,991,177.40209,861,386.02123,061,070.78155,327,555.14371,832,951.81264,213,401.79116,003,166.55
 利润总额(元) 128,718,509.7866,708,020.64-425,380,792.91258,818,616.57205,526,588.37120,290,804.99315,159,059.44533,185,880.88401,012,488.60116,370,495.72
 净利润(元) 98,214,427.6052,846,955.50-480,679,585.18212,645,545.78172,780,722.76101,584,922.00214,009,704.05443,798,316.63332,971,470.2999,237,563.89
 归属于母公司股东的净利润(元) 93,005,351.6350,855,115.49-488,844,750.60207,683,729.50169,143,389.02101,030,988.13203,285,186.73434,902,726.40325,245,253.2898,071,895.99
盈利能力:
 销售毛利率(%) 55.2955.6358.1258.8756.0052.2758.4758.3459.1455.65
 销售净利率(%) 7.588.68-16.2310.9813.5715.617.6622.5925.9715.64
 净资产收益率(%) 2.481.33-13.034.944.042.45----
 总资产报酬率ROA(%) 2.591.26-7.514.893.772.17----
 投入资本回报率ROIC(%) 2.261.23-11.174.343.572.134.409.347.002.09
营运能力:
 存货周转率(次) 1.570.894.632.611.771.14----
 应收账款周转率(次) 2.660.974.213.632.110.96----
 总资产周转率(次) 0.240.110.560.350.230.12----
偿债能力:
 资产负债率(%) 32.5230.3630.6626.1324.9225.7626.9621.9221.5421.32
 股东权益比率(%) 66.7969.0268.7673.4274.6473.8672.6777.7477.4777.18
 已获利息倍数(倍) 15.98303.05-14.3719.92103.98-66.5752.18-526.6085.8416.14
 流动比率 1.802.011.932.301.981.971.862.152.172.24
 速动比率 1.371.641.641.901.621.691.591.711.791.84
发展能力:
 营业收入增长率(%) 1.71-6.415.98-1.40-0.672.57-7.09-9.18-15.08-23.34
 营业利润增长率(%) -37.45-44.49-367.06-29.00-20.576.08-57.7822.7838.0129.62
 税后利润增长率(%) -45.01-49.66-340.47-52.25-48.003.02-22.9685.06113.8535.43
 净资产增长率(%) -18.28-15.70-15.41-2.80-2.510.791.366.647.594.35
 总资产增长率(%) -8.67-9.79-10.592.921.185.325.787.459.786.11

前瞻产业研究院